The incidence of metastatic (stage 4) breast cancer in women ages 25 to 39 has doubled in recent decades. The diagnosis often happens during or after a pregnancy, leaving thwaw young mothers with a terminal illness and life expectancy of only 2-3 years.

Jennifer Hendryx of Westlake, OH was one of those young mothers. The only hope for women like Jennifer is research – specifically research with the goal to extend lives of those already living the the disease. Unfortunately, less than 5% of research funding in the United States goes towards this type of research.